logo

hydrogen as a means of controlling and preventing COVID-19

PDF Publication Title:

hydrogen as a means of controlling and preventing COVID-19 ( hydrogen-as-means-controlling-and-preventing-covid-19 )

Next Page View | Return to Search List

Text from PDF Page: 001

Edited by: Paolo Montuschi, Catholic University of the Sacred Heart, Italy Reviewed by: Vaidehi Thanawala, Vir Biotechnology, Inc., United States Antonio Molino, University of Naples Federico II, Italy *Correspondence: Xiaobo Huang 659492700@qq.com Rongan Liu frog007_119@qq.com †These authors have contributed equally to this work Specialty section: This article was submitted to Respiratory Pharmacology, a section of the journal Frontiers in Pharmacology Received: 18 March 2020 Accepted: 21 August 2020 Published: 15 October 2020 Citation: Yang F, Yue R, Luo X, Liu R and Huang X (2020) Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients. Front. Pharmacol. 11:543718. doi: 10.3389/fphar.2020.543718 Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients Fuxun Yang†, Ruiming Yue†, Xiaoxiu Luo, Rongan Liu* and Xiaobo Huang* Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu, China Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation. Keywords: Hydrogen, COVID-19, therapy, cytokine storm, mucus INTRODUCTION Since the Corona Virus Disease 2019 (COVID-19) was first reported in Wuhan at the end of December 2019, it quickly became the sixth-largest public health emergency and a matter of international concern (Lai et al., 2020). Up to 11:00 on July 31, 2020, there were 17,328,002 confirmed cases in the world, and the cumulative number of deaths was 670,287 with an overall mortality rate of 3.8% (https://covid19.who.int/). Moreover, there is no specific antiviral drug or vaccine that could be used to prevent COVID-19. Huang et al. (2020) found that the plasma concentrations of IL-2, IL-7, IL-10, and TNF-a in severe or critical patients were higher than those in other patients. This is consistent with the pathological findings of Wang Fushen (Liu et al., 2020; Xu Z. et al., 2020). Therefore, Chen et al. propose that cytokine storm is one of the most important factors of the disease in critically ill patients (Chen et al., 2020). Currently, there is no specific drug that can be used to treat cytokine storms. Hydrogen is a colorless, odorless, and tasteless gas. In 2007, Ohsawa et al. (2007) published a paper in Nature outlining that the inhalation of 2% hydrogen could selectively eliminate hydroxyl radical (OH) and peroxynitrite anion (ONOO−) and significantly improve cerebral ischemia- reperfusion injury in rats, which has initiated an upsurge in molecular biology research based on hydrogen. To date, the biological effects of hydrogen have been widely studied. Based on its biological effects, such as in anti-oxidation, anti-inflammation, anti-apoptosis, and hormone regulatory, it has been established that hydrogen has protective effects against a variety of diseases. In particular, the small molecular properties of hydrogen ensure that it quickly reaches the alveoli, which suggests a unique advantage for lung diseases. Given the current epidemic and based on clinical experience, safety, operability, and simple clinical promotion, this review discusses the feasibility of hydrogen as a means of controlling and preventing COVID-19. HYPOTHESIS AND THEORY published: 15 October 2020 doi: 10.3389/fphar.2020.543718 Frontiers in Pharmacology | www.frontiersin.org 1 October 2020 | Volume 11 | Article 543718

PDF Image | hydrogen as a means of controlling and preventing COVID-19

hydrogen-as-means-controlling-and-preventing-covid-19-001

PDF Search Title:

hydrogen as a means of controlling and preventing COVID-19

Original File Name Searched:

fphar-11-543718.pdf

DIY PDF Search: Google It | Yahoo | Bing

Molecular Hydrogen: Clinically researched and proven as a antioxidant and more... More Info

Molecular Hydrogen Machine: Cart mounted molecular hydrogen machine for infusing antioxidant hydrogen into oils and making high value skin creams... More Info

Infinity Supercritical 10L CO2 Extractor: Supercritical CO2 Hemp Oil Extraction for Full Spectrum Botanical Oil which retains the terpenes and other valuable plant components during extraction. System runs silent with small footprint of 24 inches by 48 inches... More Info

Infinity Supercritical has developed the most profitable Supercritical CO2 Extraction Machines. Our CO2 terpene extraction system rapidly produces shelf-ready oils which make more money. Perfect for hemp oil extraction using environmentally friendly CO2 extraction equipment. Manufactures efficient oil extraction systems and machines for natural terpenes, flavorings, fragrance, hemp, beer hops, lavender and other botanicals. New for 2021 includes Molecular Hydrogen Skin Cream Machine for production of high value cosmetic skin cream. Silent technology includes supercritical co2, oil-to-oil extraction using induction magnetic mixing, and eco friendly hydrodynamic cavitation water as the solvent in our closed-looped systems. The process can also be used for electrowinning, e-waste recycling, and lithium battery recycling, gold mining electronic wastes, precious metals. CO2 can also be used in a reverse fuel cell with nafion to make a gas-to-liquids fuel, such as methanol, ethanol and butanol or ethylene. Supercritical CO2 has also been used for treating nafion to make it more effective catalyst. SCO2 can remove water from wood as an alternative to conventional kiln drying.

CONTACT TEL: 608-238-6001 Email: greg@infinitysupercritical.com | RSS | AMP